Host-targeting oral antiviral drugs to prevent pandemics by Dwek, RA, Bell, JI, Feldmann, M, Zitzmann, N

Towards the first antibody-free serum biomarker assay for NAFLD by Gangadharan, B, Kumar, A, Cobbold, J, Thursz, M, Dwek, RA, Zitzmann, N

P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 by Wilson IA, Dwek RA, Wormald MR, Scanlan CN, Doores KJ, Fulton Z, Davis BG

Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response by Sayce, AC, Martinez, FO, Tyrrell, BE, Perera, N, Hill, ML, Dwek, RA, Miller, JL, Zitzmann, N

P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity by Burton DR, Wilson IA, Dwek RA, Wormald MR, Scanlan CN, Fulton Z, Doores KJ, Davis BG

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients by Gangadharan, B, Bapat, M, Rossa, J, Antrobus, R, Chittenden, D, Kampa, B, Barnes, E, Klenerman, P, Dwek, RA, Zitzmann, N

COVID-19 therapeutics: challenges and directions for the future by Robinson, PC, Liew, DFL, Tanner, HL, Grainger, JR, Dwek, RA, Reisler, RB, Steinman, L, Feldmann, M, Ho, L-P, Hussell, T, Moss, P, Richards, D, Zitzmann, N

Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections by Warfield, K, Alonzi, DS, Hill, JC, Caputo, AT, Roversi, P, Kiappes, JL, Sheets, N, Duchars, M, Dwek, RA, Biggins, J, Barnard, D, Shresta, S, Treston, A, Zitzmann, N

Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases – not glycolipid processing enzymes by Sayce, AC, Alonzi, DS, Killingbeck, SS, Tyrrell, BE, Hill, ML, Caputo, AT, Iwaki, R, Kinami, K, Ide, D, Kiappes, JL, Beatty, PR, Kato, A, Harris, E, Dwek, RA, Miller, JL, Zitzmann, N

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease by Ersek, A, Xu, K, Antonopoulos, A, Butters, TD, Santo, AE, Vattakuzhi, Y, Williams, LM, Goudevenou, K, Danks, L, Freidin, A, Spanoudakis, E, Parry, S, Papaioannou, M, Hatjiharissi, E, Chaidos, A, Alonzi, DS, Twigg, G, Hu, M, Dwek, RA, Haslam, S, Roberts, I, Dell, A, Rahemtulla, A, Horwood, NJ, Karadimitris, A

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4 by Warfield, KL, Plummer, EM, Sayce, AC, Alonzi, DS, Tang, W, Tyrrell, BE, Hill, ML, Caputo, AT, Killingbeck, SS, Beatty, PR, Harris, E, Iwaki, R, Kinami, K, Ide, D, Kiappes, JL, Kato, A, Buck, MD, King, K, Eddy, W, Khaliq, M, Sampath, A, Treston, AM, Dwek, RA, Enterlein, SG, Miller, JL, Zitzmann, N, Ramstedt, U, Shresta, S

Neutralizing antibodies to SARS-CoV-2 selected from a human antibody library constructed decades ago by Qiang, M, Ma, P, Li, Y, Liu, H, Harding, A, Min, C, Wang, F, Liu, L, Yuan, M, Ji, Q, Tao, P, Shi, X, Li, Z, Li, T, Wang, X, Zhang, Y, Wu, NC, Lee, C-CD, Zhu, X, Gilbert-Jaramillo, J, Zhang, C, Saxena, A, Huang, X, Wang, H, James, W, Dwek, RA, Wilson, IA, Yang, G, Lerner, RA